[Malignant syndromes and sudden death, during treatments with simple and delayed-action neuroleptic drugs].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001833:Body Temperature Regulation / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D002648:Child; D002675:Child, Preschool; D003645:Death, Sudden; D003692:Delayed-Action Preparations / Q000009:adverse effects; D004402:Dysautonomia, Familial / Q000139:chemically induced*; D005260:Female; D005334:Fever / Q000139:chemically induced*; D005476:Fluphenazine / Q000009:adverse effects; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects; D012769:Shock / Q000139:chemically induced*; D014149:Tranquilizing Agents / Q000009:adverse effects*
D003692:Delayed-Action Preparations; D014149:Tranquilizing Agents; D005476:Fluphenazine
Syndromes malins et morts subites au cours des traitements par neuroleptiques simples et retard.